Results 71 to 80 of about 1,077,342 (332)

Ultralong-lasting plasma-activated water: production and control mechanisms

open access: yesPlasma Sources Science & Technology
Despite the rapidly growing interest stemming from the broad-spectrum, high inactivation capacity, and environmental friendliness of the plasma-activated water (PAW), practical applications are limited because of the PAW’s short lifetime.
Cong-fu Ran   +4 more
semanticscholar   +1 more source

Design of a new type of coating for the controlled release of heparin [PDF]

open access: yes, 1997
Thrombus formation at the surface of blood contacting devices can be prevented by local release of heparin. Preferably, the release rate should be constant for prolonged periods of time.
Engbers, G.H.M.   +4 more
core   +3 more sources

The pyruvate generator is a common phenomenon in mitochondria from different rat and mouse brain regions

open access: yesFEBS Letters, EarlyView.
The pyruvate generator, which causes activation of respiration by extra‐mitochondrial Ca2+, is also present and functional in rat brainstem mitochondria, as it is in other brain regions. This finding is confirmed by experiments with a fully reconstituted malate–aspartate shuttle (MAS).
Grazyna Debska‐Vielhaber   +7 more
wiley   +1 more source

A Nitrogen Alternative: Use of Plasma Activated Water as Nitrogen Source in Hydroponic Solution for Radish Growth [PDF]

open access: yesPlasma chemistry and plasma processing
The study investigates the potential of Plasma-Activated Water (PAW) as a nitrogen supplement in hydroponic cultivation (HS-N + PAW), specifically focusing on radish seed germination and subsequent plant growth.
Vikas Rathore, S. Nema
semanticscholar   +1 more source

Enhancement of Shelf Life of Citrus Limon L. (Lemon) Using Plasma Activated Water

open access: yesPlasma chemistry and plasma processing, 2023
The present study investigates the impact of plasma-activated water (PAW) on the shelf life of Lemon ( Citrus Limon L.). The plasma is characterized using voltage-current waveform, and the species/radicals formed in the plasma are detected using optical ...
Vikas Rathore, S. Nema
semanticscholar   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Psoralen and ultraviolet A light treatment directly affects phosphatidylinositol 3-kinase signal transduction by altering plasma membrane packing [PDF]

open access: yes, 2016
Psoralen and ultraviolet A light (PUNTA) are used to kill pathogens in blood products and as a treatment of aberrant cell proliferation in dermatitis, cutaneous T-cell lymphoma, and graft versus-host disease.
Compernolle, Veerle   +7 more
core   +2 more sources

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy